Search | IOVS | ARVO Journals

Showing 1 – 20 of 33

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Germline and somatic mutations in uveal melanomas recurring after eye preserving local treatments

Mohamed H Abdel-Rahman; Peter Johansson; Maha Hussein; Lindsey Byrne; Frederick H Davidorf; Nicholas Hayward; Colleen M Cebulla

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2256.

ARVO Annual Meeting Abstract June 2024

Frequent germline alterations in uveal melanoma patients referred for genetic counseling

Colleen M Cebulla; Lindsey Byrne; Emma Schreiner; Frederick H Davidorf; Mohamed H Abdel-Rahman

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4279.

ARVO Annual Meeting Abstract June 2022

Germline MBD4 variants in uveal melanoma patients

Mohamed H Abdel-Rahman; Peter Johansson; Frederick H Davidorf; Nicholas Hayward; Colleen M Cebulla

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2354 – A0023.

ARVO Annual Meeting Abstract June 2022

Clinical Phenotype and Genetics of Familial Uveal Melanoma

Tara Salmans; Aliya Ansari; Lindsey Byrne; Frederick H Davidorf; Colleen M Cebulla; Mohamed H Abdel-Rahman

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2360 – A0029.

Articles March 2022

Use and Perceptions of Advanced Driver Assistance Systems by Older Drivers With and Without Age-Related Macular Degeneration

PDF

Rebecca A. Deffler; Jing Xu; Ava K. Bittner; Alex R. Bowers; Shirin E. Hassan; Nicole Ross; San-San L. Cooley; Aprile Doubt; Frederick H. Davidorf; Bradley E. Dougherty; for the RADARS Study Group
TAGS: age-related macular degeneration, antidrug antibody, older drivers, perception, surveys, avoidance behavior, safety
Trans. Vis. Sci. Tech.. 2022; 11(3):22. https://doi.org/10.1167/tvst.11.3.22

ARVO Annual Meeting Abstract June 2021

BAP1 status and response to radiation in melanoma

Pranita Hanpude; James Brandon Massengill; Colleen M Cebulla; Frederick Davidorf; Mohamed H Abdel-Rahman

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):2872.

ARVO Annual Meeting Abstract June 2021

Perceptions of Advanced Driver Assistance Systems by People with and without Age-Related Macular Degeneration

Rebecca A Deffler; San-San Cooley; Aprile Doubt; Frederick Davidorf; Jing Xu; Abbie Hutton; Ava K Bittner; Alex R Bowers; Andrés Guerrero-Criado; Shirin E Hassan; Nicole Ross; Anusha Bhojani; Bradley E Dougherty

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3552.

ARVO Annual Meeting Abstract June 2020

Mediators of the relationship between socioeconomic status and visual acuity in age-related macular degeneration

Rebecca A Deffler; San-San Cooley; Frederick Davidorf; Bradley E Dougherty

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1572.

ARVO Annual Meeting Abstract June 2020

Study of the role of germline variants in MBD4 in predisposition to uveal melanoma and exceptional clinical outcomes.

Mohamed H Abdel-Rahman; James B Massengill; Robert Pilarski; Frederick H Davidorf; Colleen M Cebulla

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2829.

ARVO Annual Meeting Abstract June 2020

Somatic Alterations in Uveal Melanoma Tumors from Patients with Strong Personal and/or Family History of Cancer

Saurabh Pancholi; Timothy Grosel; James B Massengill; Robert Pilarski; Frederick H Davidorf; Colleen M Cebulla; Mohamed H Abdel-Rehman

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2831.

ARVO Annual Meeting Abstract July 2019

Promoter methylation of RASSF1 is common in non-tumor choroid tissue

Sabrina Yasmin Bulas; Saurabh Pancholi; James Massengill; Frederick Davidorf; Colleen M Cebulla; Mohamed H Abdel-Rahman

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):755.

ARVO Annual Meeting Abstract July 2019

Exploratory study of candidate genes other than BAP1 associated with hereditary predisposition to uveal melanoma

Mohamed H Abdel-Rahman; Klarke M Sample; Timothy Grosel; Ben Kelly; David Gordon; Maciej Pietrzak; Robert Pilarski; Frederick Davidorf; Peter White; Colleen M Cebulla

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):958.

ARVO Annual Meeting Abstract July 2019

Evaluation of the imaging features of Presumed Ocular Histoplasmosis Syndrome using Optical Coherence Tomography Angiography

Jack Li; Frederick Davidorf

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4539.

Anatomy and Pathology/Oncology June 2019

Heterogeneity in Mitogen-Activated Protein Kinase (MAPK) Pathway Activation in Uveal Melanoma With Somatic GNAQ and GNA11 Mutations

PDF

Getachew Boru; Colleen M. Cebulla; Klarke M. Sample; James B. Massengill; Frederick H. Davidorf; Mohamed H. Abdel-Rahman
TAGS: heterogeneity, intraocular melanoma, mitogen-activated protein kinases, mutation, neoplasms, cell lines, immunohistochemistry, transfection
Invest. Ophthalmol. Vis. Sci.. 2019; 60(7):2474-2480. https://doi.org/10.1167/iovs.18-26452

Includes: Supplemental Content

ARVO Annual Meeting Abstract July 2018

Identification of novel targeted therapies for BAP1 mutated tumors

Mohamed H Abdel-Rahman; Leili Shahriyari; James B Massengill; Kari Kendra; Thomas Olencki; Frederick H Davidorf; Colleen M Cebulla

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4958.

ARVO Annual Meeting Abstract July 2018

Vision, Stress, Depression, and Number of Anti-VEGF Treatments in Age-related Macular Degeneration

Bradley E Dougherty; Ellen E Segerstrom; San-San L Cooley; Frederick H Davidorf

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5192.

ARVO Annual Meeting Abstract July 2018

MIF promoter polymorphism variations in retinal detachment with proliferative vitreoretinopathy

Colleen M Cebulla; Heather Van Law; Bongsu Kim; Rania Kusibati; Tyler Heisler-Taylor; Demarcus Williams; Jay Matthias; Frederick H. Davidorf; Matthew Ohr; Michael Wells; Dino Klisovic; John B Allen; William Terrell; Daniel M Miller; Robert Pilarski; Mohamed H Abdel-Rahman

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1156.

ARVO Annual Meeting Abstract June 2017

Evaluation of Germline Variants in the Promotor Region of Macrophage Migration Inhibitory Factor (MIF) in Uveal Melanoma Patients

Stanley Park; Benjamin Romney; Khara Walker; Robert Pilarski; Lynn Schoenfield; Frederick Davidorf; Colleen M Cebulla; Mohamed H. Abdel-Rahman

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3961.

ARVO Annual Meeting Abstract June 2017

Hepatic arterial melphalan perfusion of liver predominant uveal melanoma metastasis

Annahita Amireskandari; Georgia Beasley; Anne Kunkler; Srinivas Kondapalli; Thomas Olencki; Mark Bloomston; Carl Schmidt; Mohamed H. Abdel-Rahman; Robert Pilarski; Frederick Davidorf; Colleen M Cebulla

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3971.

ARVO Annual Meeting Abstract June 2017

Optimization of retinal detachment vitreous sample preparation methods for protein analysis

Bongsu Kim; Bernard Wen; Rania Kusibati; Tyler Nicholas Heisler-Taylor; Frederick Davidorf; Matthew P Ohr; Michael B Wells; Dino D Klisovoc; John B Allen; Sanjoy K Bhattacharya; Colleen M Cebulla

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):5963.

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Germline and somatic mutations in uveal melanomas recurring after eye preserving local treatments

Frequent germline alterations in uveal melanoma patients referred for genetic counseling

Germline MBD4 variants in uveal melanoma patients

Clinical Phenotype and Genetics of Familial Uveal Melanoma

Use and Perceptions of Advanced Driver Assistance Systems by Older Drivers With and Without Age-Related Macular Degeneration

BAP1 status and response to radiation in melanoma

Perceptions of Advanced Driver Assistance Systems by People with and without Age-Related Macular Degeneration

Mediators of the relationship between socioeconomic status and visual acuity in age-related macular degeneration

Study of the role of germline variants in MBD4 in predisposition to uveal melanoma and exceptional clinical outcomes.

Somatic Alterations in Uveal Melanoma Tumors from Patients with Strong Personal and/or Family History of Cancer

Promoter methylation of RASSF1 is common in non-tumor choroid tissue

Exploratory study of candidate genes other than BAP1 associated with hereditary predisposition to uveal melanoma

Evaluation of the imaging features of Presumed Ocular Histoplasmosis Syndrome using Optical Coherence Tomography Angiography

Heterogeneity in Mitogen-Activated Protein Kinase (MAPK) Pathway Activation in Uveal Melanoma With Somatic GNAQ and GNA11 Mutations

Identification of novel targeted therapies for BAP1 mutated tumors

Vision, Stress, Depression, and Number of Anti-VEGF Treatments in Age-related Macular Degeneration

MIF promoter polymorphism variations in retinal detachment with proliferative vitreoretinopathy

Evaluation of Germline Variants in the Promotor Region of Macrophage Migration Inhibitory Factor (MIF) in Uveal Melanoma Patients

Hepatic arterial melphalan perfusion of liver predominant uveal melanoma metastasis

Optimization of retinal detachment vitreous sample preparation methods for protein analysis

To View More...

You must be signed into an individual account to use this feature.